Sekisui Diagnostics Revenue and Competitors

SEKISUI Diagnostics, a global provider of innovative medical diagnostics to physicians and laboratories, has been committed to improving the lives of patients for over 30 years. We continue to invest in new diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. We are a leading provider of rapid tests in the U.S., and high throughput coagulation systems in Japan. We develop, manufacture, and supply over 1.7 billion tests each year to the global healthcare market through direct sales, our commercial distribution networks and our partners. \n\nOur product lines include: \n• Clinical chemistry systems and reagents \n• Coagulation systems and reagents \n• Point of care rapid tests and immunoassay system\n• Enzymes, specialty biochemicals \n\nHeadquartered in Lexington, MA, our history of innovation includes the first homogeneous test for LDL and the first plastic vacuum blood collection tube. With more than 450 employees spread across 6 sites in four countries, we are a worldwide company with R&D and manufacturing on three continents. As a sister company to Sekisui Medical in Japan, we are globally positioned to meet your diagnostics needs.